Epimedium Extract

Main Active Ingredients:
Icariin – CAS: 489-32-7 | Assay: 10%-98% By HPLC|
Application: men’s-health & vitality supplements | bone-health formulas | healthy-aging & longevity stacks | TCM-format practitioner supplements
MOQ: 1KG|US Warehouse Stock Available — ships within 2 business days for US customers
Certifications: ISO, HACCP, GMP, Kosher, Halal, Organic, BRC, FDA Compliant

Thank you for sharing our article through the button

Facebook
X
LinkedIn
Telegram
Reddit

Bulk Epimedium Extract Supplier — Icariin 10%, 20% & 98% HPLC, B2B Wholesale

Written by Jonathan, Valeherb · Reviewed by Dr. Xiaoyan Qiu · Updated June 2026

Valeherb supplies Epimedium extract bulk wholesale — standardized Yin Yang Huo (淫羊藿), also known as horny goat weed — in three icariin grades: 10%, 20%, and 98% icariin by HPLC. Derived from the aerial parts of Epimedium grandiflorum, E. brevicornu, E. pubescens, and other pharmacopoeially recognized species, icariin-standardized Epimedium is one of the most commercially significant botanical actives in the men’s-health and healthy-aging supplement categories. Custom extraction ratios and ChP-compliant specifications are available on request.


Icariin, Icariside II, and Icaritin: Understanding the Compound Hierarchy

Three related compounds define the Epimedium specification landscape. Valeherb’s standardized products are the icariin grades (10–98%); icariside II and icaritin are shown here for specification context, as buyers sometimes conflate them with icariin.

Compound Structure Research Characterization Bioavailability
Icariin Prenylated flavonol glycoside — parent compound Studied in research for PDE5, osteoblast, and antioxidant activity[1] Lower oral bioavailability — undergoes intestinal hydrolysis to metabolites
Icariside II (Baohuoside I) Mono-glycoside — primary metabolite of icariin Studied for greater PDE5 activity than icariin in research; improved membrane permeability[2] Higher — absorbed more readily than the parent glycoside
Icaritin Aglycone — fully deglycosylated form Studied in estrogenic-pathway and bone research; distinct activity profile Highest of the three, with a notably different activity profile
KEY POINT
The most common specification gap in Epimedium procurement is requesting “icariin 20%” without clarifying which compound is meant. Icariin (parent glycoside), icariside II, and icaritin have different molecular weights, bioavailability profiles, and activity mechanisms — they are not interchangeable specifications. Always request HPLC with individual compound identification on the COA. Valeherb standardizes to icariin; specify if a project instead requires the icariside II or icaritin compound.

Available Grades and Specifications

Grade Icariin Content (HPLC) Appearance Typical Downstream Application
Standard Extract 10% icariin Brown to light-brown powder Entry-level men’s-health blends, herbal supplement stacks, TCM-format formulas
Standardized Extract 20% icariin Light-brown to tan powder Mainstream men’s-health and bone-health capsules; the most common commercial specification
High-Purity Icariin 98% icariin Lemon-yellow powder Premium formulas, research applications, analytical reference, maximum standardized potency

The 98% icariin isolate is a characteristic lemon-yellow powder — a useful visual identity check alongside HPLC verification (lower-percentage extracts are browner due to residual plant matrix). All grades are standardized by HPLC against a certified icariin reference standard and ship with a per-batch COA.


Research Across Three Areas

1. Male Vitality and Circulation

Icariin has been studied in research for phosphodiesterase-5 (PDE5) activity and for nitric-oxide-mediated effects on vascular tone. A 2010 primary in-vitro and in-vivo study (Shindel et al.) examined icariin’s PDE5-inhibitory and neurotrophic effects in cell and animal models.[2] The magnitude of PDE5 activity reported for icariin in research is far below that of pharmaceutical PDE5 inhibitors — relevant context for compliant label positioning. On finished products, compliant structure/function language such as “supports male reproductive health” or “supports healthy circulation” is appropriate under DSHEA; drug-equivalent or erectile-dysfunction-treatment claims are not.

2. Bone Metabolism

Icariin has been characterized in research for effects on bone-cell activity (osteoblast and osteoclast pathways). A 2025 systematic review and meta-analysis of randomized controlled trials (Zhang et al., 10 RCTs) examined Epimedium and its active components in bone-density research.[3] This supports Epimedium’s relevance in the bone-health supplement category, where compliant claims are limited to “supports bone health”-type structure/function wording.

3. Antioxidant Activity

A review by Sze et al. (2010) characterized the antioxidant properties of Herba Epimedii and its flavonoids, linking activity to induction of endogenous free-radical-scavenging enzymes (catalase, glutathione peroxidase) and the electron-donating capacity of flavonoids.[1] Antioxidant is among the most readily substantiated structure/function claim types and broadens Epimedium’s positioning within healthy-aging stacks.

The above describe published research on the Epimedium compounds and are provided for informational purposes only; they are not claims for any finished product.


Formulation Applications

  • Men’s-health supplements: 20% icariin at 300–500 mg per serving is the common format; the 98% isolate is used where a precise, high-potency icariin dose is required. Pairs with Tribulus terrestris, maca root, and zinc in comprehensive men’s-wellness formulas
  • Bone-health formulas: 20% extract alongside calcium, vitamin D3, and vitamin K2, with claims kept to compliant “supports bone health” structure/function wording — a growing category for adults over 50
  • Healthy-aging stacks: Combined with NMN, resveratrol, and Cistanche extract for multi-ingredient positioning; the antioxidant profile is the most defensible cross-category claim basis
  • TCM-format practitioner supplements: 10% standard extract in traditional Yin Yang Huo formulas; ChP 2020 compliance documentation available

Sourcing Criteria

Criterion What to Require
Compound-Specific HPLC Specify icariin as the marker and require individual compound identification on the HPLC COA against a certified reference standard — not just “total flavonoids.” Confirm it is icariin (not icariside II or icaritin)
Species Documentation Confirm Epimedium species on the COA. ChP 2020 lists E. brevicornu, E. sagittatum, E. pubescens, E. wushanense, and E. koreanum under the Herba Epimedii monograph[4]
Plant Part Aerial parts (leaves and stems) — the commercial source for icariin-standardized extract. Root has a different profile
Third-Party COA Icariin content (HPLC), heavy metals (USP <232>), pesticide residues, microbial limits (USP <2021>), moisture — per production batch from an accredited laboratory
Certifications Non-GMO; Kosher/Halal for relevant markets; FDA-registered facility for US supplement supply
CAUTION
Phytoestrogenic activity & interactions: Epimedium flavonoids have documented phytoestrogenic activity, so precautionary labeling is advisable for individuals with hormone-sensitive conditions, and concurrent use with hormone therapy should be undertaken only with healthcare-professional guidance. A theoretical interaction with anticoagulant medications has been described (mild platelet effects at high doses). Use during pregnancy is not recommended given phytoestrogenic activity and insufficient controlled data. Isolated case reports describe cardiac arrhythmia at very high doses; label a clear maximum daily dose. These are objective safety considerations and do not imply any therapeutic effect of the finished product.

Regulatory Guidance

FDA NOTICE
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Required on all dietary-supplement products sold in the United States.
  • US (DSHEA): Structure/function claims (e.g., male reproductive health, healthy circulation, bone health, antioxidant support) must be substantiated and disclaimed by the marketer; antioxidant-type claims are typically the most readily supported. PDE5-mechanism references require careful wording — any claim implying pharmaceutical-equivalent efficacy or erectile-dysfunction treatment is a drug claim requiring NDA approval
  • China (ChP 2020): Herba Epimedii (淫羊藿) is a listed medicinal herb with a standardized monograph covering five accepted species[4]
  • EU: Not on the EU authorized health-claims register; traditional-use status may apply in some member states
  • Canada (NHPs): Epimedium (Yin Yang Huo) has a licensed Health Canada monograph; permitted claims are defined by that monograph
FOR MARKETERS
Pharmacopoeial and research references on this page describe the raw ingredient and published science on its compounds — they do not pre-substantiate any finished-product claim. Erectile-dysfunction, osteoporosis, anti-cancer, or other disease wording is a drug claim. All finished-product claims, substantiation, and labeling are the marketer’s responsibility in the destination market.

References

[1] Sze SCW, Tong Y, Ng TB, Cheng CLY, Cheung HP. (2010). Herba Epimedii: anti-oxidative properties and its medical implications. Molecules, 15(11), 7861–7870. doi:10.3390/molecules15117861

[2] Shindel AW, Xin Z-C, Lin G, et al. (2010). Erectogenic and neurotrophic effects of icariin, a purified extract of horny goat weed (Epimedium spp.) in vitro and in vivo. Journal of Sexual Medicine, 7(4 Pt 1), 1518–1528. doi:10.1111/j.1743-6109.2009.01699.x

[3] Zhang X-Q, Hua Z-H, Huang C-J, et al. (2025). The efficacy and safety of Epimedium in the treatment of primary osteoporosis: a systematic review and meta-analysis. Frontiers in Medicine, 12, 1675160. doi:10.3389/fmed.2025.1675160

[4] Chinese Pharmacopoeia Commission. (2020). Herba Epimedii (淫羊藿). In: Pharmacopoeia of the People’s Republic of China, Vol. I. China Medical Science Press.

FAQ

A1:They are related but distinct compounds. Icariin is the parent flavonol glycoside; icariside II (baohuoside I) is its mono-glycoside metabolite with higher membrane permeability; and icaritin is the fully deglycosylated aglycone with a different activity profile. They have different molecular weights and are not interchangeable specifications. Valeherb standardizes to icariin (10%, 20%, 98%); specify separately if a project requires icariside II or icaritin.
A2:High-purity 98% icariin is a characteristic lemon-yellow powder. Lower-percentage extracts (10–20%) are browner because of the residual plant matrix. Color is a useful first-pass identity check, but it does not replace HPLC verification against a certified reference standard.
A3:It depends on the format and positioning. 10% suits traditional TCM-format and entry-level blends; 20% is the common mainstream specification for men’s-health and bone-health capsules; and the 98% isolate is for premium formulas, precise high-potency dosing, research use, or analytical reference. All three are HPLC-standardized with a per-batch COA.
A4:Because Epimedium flavonoids have phytoestrogenic activity, precautionary labeling is advisable for people with hormone-sensitive conditions, and it should not be combined with hormone therapy without professional guidance. It is not recommended during pregnancy, and a theoretical interaction with anticoagulant medications has been described. These are objective safety considerations for the finished-product label.

SEND INQUIRY

Contact Form Demo

The essence of natural sweetness — extracted directly from plants

The most promising sugar-free and zero-calorie sweetener usage guide for 2026

Understand the gap between natural sweeteners and synthetic sweeteners